Annual ROE
-1904.94%
-1553.71%-442.36%
December 31, 2022
Summary
- As of March 10, 2025, SRNE annual return on equity is -1904.94%, with the most recent change of -1553.71% (-442.36%) on December 31, 2022.
- During the last 3 years, SRNE annual ROE has fallen by -1702.16% (-839.41%).
- SRNE annual ROE is now -301.01% below its all-time high of 947.69%, reached on December 31, 2005.
Performance
SRNE ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
1008.60%
+1978.31%+204.01%
June 30, 2023
Summary
- As of March 10, 2025, SRNE quarterly return on equity is 1008.60%, with the most recent change of +1978.31% (+204.01%) on June 30, 2023.
- Over the past year, SRNE quarterly ROE has increased by +1978.31% (+204.01%).
- SRNE quarterly ROE is now at all-time high.
Performance
SRNE Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
SRNE ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -442.4% | +204.0% |
| 3 y3 years | -839.4% | +204.0% |
| 5 y5 years | -10000.0% | +204.0% |
SRNE ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -442.4% | at low | at high | +204.0% |
| 5 y | 5-year | -839.4% | at low | at high | +204.0% |
| alltime | all time | -301.0% | at low | at high | +204.0% |
Sorrento Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | 1008.60%(-204.0%) |
| Mar 2023 | - | -969.71%(+86.4%) |
| Dec 2022 | -1904.94%(+442.4%) | -520.24%(+47.7%) |
| Sep 2022 | - | -352.21%(+1.5%) |
| Jun 2022 | - | -346.89%(+25.7%) |
| Mar 2022 | - | -276.01%(+2.2%) |
| Dec 2021 | -351.23%(+43.4%) | -270.06%(+39.8%) |
| Sep 2021 | - | -193.22%(+11.9%) |
| Jun 2021 | - | -172.68%(+25.8%) |
| Mar 2021 | - | -137.30%(-36.7%) |
| Dec 2020 | -244.90%(+20.8%) | -217.06%(-14.9%) |
| Sep 2020 | - | -254.97%(-15.8%) |
| Jun 2020 | - | -302.65%(+7.1%) |
| Mar 2020 | - | -282.53%(+6.3%) |
| Dec 2019 | -202.78%(+103.8%) | -265.79%(+31.9%) |
| Sep 2019 | - | -201.48%(+38.6%) |
| Jun 2019 | - | -145.37%(+9.6%) |
| Mar 2019 | - | -132.60%(+45.9%) |
| Dec 2018 | -99.52%(-1624.0%) | -90.88%(+79.7%) |
| Sep 2018 | - | -50.57%(+53.6%) |
| Jun 2018 | - | -32.92%(>+9900.0%) |
| Mar 2018 | - | -0.26%(-103.2%) |
| Dec 2017 | 6.53%(-112.1%) | 8.14%(-112.6%) |
| Sep 2017 | - | -64.83%(+49.5%) |
| Jun 2017 | - | -43.37%(-42.3%) |
| Mar 2017 | - | -75.17%(+33.7%) |
| Dec 2016 | -54.11%(+49.9%) | -56.21%(+2.7%) |
| Sep 2016 | - | -54.72%(-18.7%) |
| Jun 2016 | - | -67.27%(+52.3%) |
| Mar 2016 | - | -44.18%(+14.0%) |
| Dec 2015 | -36.09%(-8.6%) | -38.74%(+29.9%) |
| Sep 2015 | - | -29.82%(-28.6%) |
| Jun 2015 | - | -41.77%(-0.5%) |
| Mar 2015 | - | -41.98%(-7.0%) |
| Dec 2014 | -39.49%(-34.2%) | -45.16%(-26.2%) |
| Sep 2014 | - | -61.22%(-11.2%) |
| Jun 2014 | - | -68.98%(-19.1%) |
| Mar 2014 | - | -85.24%(-6.6%) |
| Dec 2013 | -60.02% | -91.31%(-10.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2013 | - | -102.20%(-24.0%) |
| Jun 2013 | - | -134.43%(+48.9%) |
| Mar 2013 | - | -90.30%(+10.6%) |
| Dec 2012 | -93.11%(+33.7%) | -81.67%(+11.5%) |
| Sep 2012 | - | -73.24%(-0.9%) |
| Jun 2012 | - | -73.88%(-21.4%) |
| Mar 2012 | - | -93.97%(+16.6%) |
| Dec 2011 | -69.65%(+59.5%) | -80.59%(+6.6%) |
| Sep 2011 | - | -75.57%(+6.3%) |
| Jun 2011 | - | -71.08%(+20.9%) |
| Mar 2011 | - | -58.79%(-5.5%) |
| Dec 2010 | -43.66%(+48.3%) | -62.23%(-34.3%) |
| Sep 2010 | - | -94.71%(+33.9%) |
| Jun 2010 | - | -70.75%(+14.1%) |
| Mar 2010 | - | -62.01%(+25.5%) |
| Dec 2009 | -29.44%(-234.5%) | -49.41%(+285.1%) |
| Sep 2009 | - | -12.83%(-7.8%) |
| Jun 2009 | - | -13.92%(+80.5%) |
| Mar 2009 | - | -7.71%(-75.7%) |
| Dec 2008 | 21.89%(-101.5%) | -31.72%(-75.8%) |
| Sep 2008 | - | -131.11%(-55.2%) |
| Jun 2008 | - | -292.80%(+44.9%) |
| Mar 2008 | - | -202.08%(-75.6%) |
| Dec 2007 | -1454.84%(-1662.5%) | -828.48%(-383.2%) |
| Sep 2007 | - | 292.50%(+21.1%) |
| Jun 2007 | - | 241.45%(+22.7%) |
| Mar 2007 | - | 196.84%(-79.2%) |
| Dec 2006 | 93.11%(-90.2%) | - |
| Sep 2006 | - | 946.15%(+237.2%) |
| Jun 2006 | - | 280.62%(+70.2%) |
| Mar 2006 | - | 164.87%(+41.2%) |
| Dec 2005 | 947.69%(>+9900.0%) | 116.79%(>+9900.0%) |
| Sep 2005 | - | 0.23%(0.0%) |
| Jun 2005 | - | 0.23%(-4.2%) |
| Mar 2005 | - | 0.24%(0.0%) |
| Dec 2004 | 0.23%(-4.2%) | 0.24%(+33.3%) |
| Sep 2004 | - | 0.18%(+50.0%) |
| Jun 2004 | - | 0.12%(+100.0%) |
| Mar 2004 | - | 0.06% |
| Dec 2003 | 0.24% | - |
FAQ
- What is Sorrento Therapeutics annual return on equity?
- What is the all time high annual ROE for Sorrento Therapeutics?
- What is Sorrento Therapeutics annual ROE year-on-year change?
- What is Sorrento Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Sorrento Therapeutics?
- What is Sorrento Therapeutics quarterly ROE year-on-year change?
What is Sorrento Therapeutics annual return on equity?
The current annual ROE of SRNE is -1904.94%
What is the all time high annual ROE for Sorrento Therapeutics?
Sorrento Therapeutics all-time high annual return on equity is 947.69%
What is Sorrento Therapeutics annual ROE year-on-year change?
Over the past year, SRNE annual return on equity has changed by -1553.71% (-442.36%)
What is Sorrento Therapeutics quarterly return on equity?
The current quarterly ROE of SRNE is 1008.60%
What is the all time high quarterly ROE for Sorrento Therapeutics?
Sorrento Therapeutics all-time high quarterly return on equity is 1008.60%
What is Sorrento Therapeutics quarterly ROE year-on-year change?
Over the past year, SRNE quarterly return on equity has changed by +1978.31% (+204.01%)